Enhancement of the immune response to non-replicating herpes simplex virus type-1 preparations by mucosal administration in the presence of cholera toxin

By Richards C.M.   Hill T.J.   Williams N.A.  

Vaccine, Vol. 15, Iss. 10, 1997-07 ,pp. : 1065-1069

Elsevier

Access to resources Recommend Favorite

Mucosal co-administration of cholera toxin and influenza virus hemagglutinin-DNA in ponies generates a local IgA response

By Soboll G.   Nelson K.M.   Leuthner E.S.   Clark R.J.   Drape R.   Macklin M.D.   Swain W.F.   Olsen C.W.   Lunn D.P.  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 3081-3092

Elsevier

Access to resources Recommend Favorite

Human immunodeficiency virus-1 principal neutralizing domain peptide-toxin A conjugate vaccine

By Cryz S.J.   Goldstein H.   Pettoello-Mantovani M.   Kim A.   Furer E.   Que J.U.   Hasler T.   Rubinstein A.  

Vaccine, Vol. 13, Iss. 1, 1995-01 ,pp. : 67-71

Elsevier

Access to resources Recommend Favorite

Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant

By Isaka M.   Yasuda Y.   Mizokami M.   Kozuka S.   Taniguchi T.   Matano K.   Maeyama J.-i.   Mizuno K.   Morokuma K.   Ohkuma K.   Goto N.   Tochikubo K.  

Vaccine, Vol. 19, Iss. 11, 2001-12 ,pp. : 1460-1466

Elsevier

Access to resources Recommend Favorite

Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion protein

By Moriya O.   Matsui M.   Osorio M.   Miyazawa H.   Rice C.M.   Feinstone S.M.   Leppla S.H.   Keith J.M.   Akatsuka T.  

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 789-796

Elsevier

Access to resources Recommend Favorite